BioSpace News Archive

Biotech Bay

Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discovery

Led by DFJ, Series A Financing Unites Leading Life Sciences and Technology Investors to Support a Transformative Approach to Drug Development

July 16, 2018
·
4 min read
Business

Enanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Third Quarter Ended June 30, 2018

Enanta Pharmaceuticals, Inc. announced that it plans to report its financial results for its fiscal third quarter ended June 30, 2018, after the U.S. markets close on August 7, 2018

July 16, 2018
·
2 min read
Business

Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2018

Medifast, Inc. will announce financial results for the second quarter ended June 30, 2018 on Thursday, August 2, 2018, after market close.

July 16, 2018
·
1 min read
FDA

MaxCyte Receives US FDA Investigational New Drug Clearance for First Clinical Program

Company to conduct Phase I clinical study of MCY-M11, a CAR therapeutic, in patients with ovarian cancer and peritoneal mesothelioma

July 16, 2018
·
2 min read
Policy

Certis Oncology Announces CLIA Certification for High-Complexity TestingThe Company has designed Laboratory Developed Tests for its innovative PDOX mouse modeling techniques to determine the best treatment options for cancer patients

Certis Oncology Solutions, Inc. today announced that it has received its CLIA Certificate of Registration for High-Complexity Testing.

July 16, 2018
·
3 min read
Deals

Bausch Health Companies Inc. Begins Trading Today As “BHC” On NYSE And TSX

Bausch Health Launches New Corporate Web Site

July 16, 2018
·
3 min read
Business

enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President

enGene Inc. announced the appointment of Jason D. Hanson as President, Chief Executive Officer and Director.

July 16, 2018
·
3 min read
FDA

Braeburn Announces PDUFA Date for CAM2038 for the Treatment of Opioid Use Disorder

If approved, CAM2038 will provide patients and HCPs with flexible-dose weekly and monthly options for the treatment of opioid use disorder, with the goal of improving treatment adherence and reducing the burdens associated with daily medication.

July 16, 2018
·
3 min read
Biotech Beach

Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases

Pliant Therapeutics, Inc. announced that it has raised $62 million in a Series B financing.

July 16, 2018
·
3 min read
Business

Cricket Health Appoints Dr. Carmen A. Peralta as Chief Medical Officer

Commitment to Patients at Heart of Multidisciplinary Care Program for Those with Kidney Disease

July 16, 2018
·
3 min read